BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37644196)

  • 1. Multiple brown tumors: a bone complication due to long-term untreated pseudohypoparathyroidism.
    Gonnelli S; Briot K; Cormier C; Teboul S; Roux C; Koumakis E
    Osteoporos Int; 2024 Jan; 35(1):195-199. PubMed ID: 37644196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-Fluorocholine PET/CT Imaging of Brown Tumors in a Patient With Severe Primary Hyperparathyroidism.
    Zhang-Yin J; Gaujoux S; Delbot T; Gauthé M; Talbot JN
    Clin Nucl Med; 2019 Dec; 44(12):971-974. PubMed ID: 31652163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of Brown Tumors With 18 F-Fluorocholine PET/CT Imaging in Severe Primary Hyperparathyroidism.
    Werner J; Grünig H; Loher H; Fischli S; Strobel K; Wicke C
    Clin Nucl Med; 2023 Aug; 48(8):e387-e389. PubMed ID: 37256731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient with a history of breast cancer and multiple bone lesions: a case report.
    Schnyder MA; Stolzmann P; Huber GF; Schmid C
    J Med Case Rep; 2017 May; 11(1):127. PubMed ID: 28476174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misleading localization by
    Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
    BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of brown tumors by [18F]F-choline PET/CT performed in a patient with secondary hyperparathyroidism.
    Rogic I; Huic D
    Nucl Med Rev Cent East Eur; 2023; 26(0):49-51. PubMed ID: 36856091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
    Diao Z; Zhang J; Zhao J; Sun W; Pu Z
    BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B.
    Neary NM; El-Maouche D; Hopkins R; Libutti SK; Moses AM; Weinstein LS
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3025-30. PubMed ID: 22736772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteolytic lesions (brown tumors) of primary hyperparathyroidism misdiagnosed as multifocal giant cell tumor of the distal ulna and radius: a case report.
    Panagopoulos A; Tatani I; Kourea HP; Kokkalis ZT; Panagopoulos K; Megas P
    J Med Case Rep; 2018 Jun; 12(1):176. PubMed ID: 29936913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and functional imaging employment in the differentiation of brown tumors from bone metastases in a case of primary papillary thyroid cancer and parathyroid adenoma: case report.
    Al-Rasheed U; Barakat F; Al-Ibraheem A
    J Egypt Natl Canc Inst; 2021 Oct; 33(1):30. PubMed ID: 34657985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report.
    Hussain M; Hammam M
    J Med Case Rep; 2016 Jun; 10():166. PubMed ID: 27277007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertiary Hyperparathyroidism With Renal Osteodystrophy on 18F-Fluorocholine PET/CT.
    Broos WAM; Wondergem M; van der Zant FM; Knol RJJ
    Clin Nucl Med; 2018 Oct; 43(10):766-768. PubMed ID: 30153138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR; Perlmutter S; Aloia JF
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable Bone Phenotypes in Patients with Pseudohypoparathyroidism.
    Wang Y; Lu C; Chen X
    Curr Osteoporos Rep; 2023 Jun; 21(3):311-321. PubMed ID: 37014531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets.
    Dabbagh S; Chesney RW; Langer LO; DeLuca HF; Gilbert EF; DeWeerd JH
    Am J Dis Child; 1984 Nov; 138(11):1030-3. PubMed ID: 6548601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic bone disease in pseudohypoparathyroidism: radiologic features.
    Burnstein MI; Kottamasu SR; Pettifor JM; Sochett E; Ellis BI; Frame B
    Radiology; 1985 May; 155(2):351-6. PubMed ID: 3983385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis.
    Eubanks PJ; Stabile BE
    Arch Surg; 1998 Jun; 133(6):673-6. PubMed ID: 9637471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.